Xencor, Inc. (XNCR)
$24.63+0.53%Close
SELLRECOVERY · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.8B
- Beta
- 0.90
- P/E (TTM)
- -11.23
- Short % float
- 30.08%
- Days to cover
- 10.1
- SI change
- +3.9%
- 1W
- -0.85%
- 1M
- +1.53%
- vs SPY 1W
- -2.01%
- vs SPY 1M
- -1.47%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on XNCR?
- LOPJLB’s latest quantitative signal on Xencor, Inc. (XNCR) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is XNCR in?
- Xencor, Inc. (XNCR) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Xencor, Inc. (XNCR) do?
- Xencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. Its central mission involves the discovery and sophisticated engineering of monoclonal antibody and cytokine therapeutics, primarily aimed at treating patients afflicted with cancer and autoimmune disorders. The company is associated with several notable the…